Oncotarget is a multidisciplinary conventional journal. Oncotarget has free access. It publishes papers online every week. Every article or issue can be printed on special demand. The ultimate purpose of Oncotarget is to avail scientific results widely in a fast manner and to enable quick sharing of exceptional discoveries. Oncotarget also seeks to connect different biomedical science fields and to foster applications of clinical and basic science to battle disease.
Oncotarget is led by the most prominent scientists and assists all researchers in contributing to science progress. The mission of the company is to see a life without disease. Oncotarget has grown and expanded to become a successful journal since its inception in 2010. Oncotarget decided to launch sections other than oncology due to this success.
According to Research Gate, the word “Oncotarget” covers all pathways, molecules, and cellular functions popular in aging and cancer, atherosclerosis, neurodegeneration, neurons, lymphocytes, microbes, and cancer cells. The Editors-in-chief of Oncotarget are Mikhail V. Blagosklonny and Andrei V. Gudkov. Both of them are scientists at the Roswell Park Cancer Institute, Buffalo, NY.
Two members who serve in Oncotarget’s Editorial Board by the names Gregg L. Semenza and William G. Kaelin were awarded the Lasker Award for their contributions to the discovery of the Oxygen-sensing Pathway in 2016. This came as a big honor for Oncotarget. Oncotarget has been able to publish more than 370 papers on topics that are related to oxygen since 2010.
The Editorial Board at Oncotarget is made up of experienced and qualified scientists who share the goal of the journal to eliminate the disease. They all work at different health and medical institutions. Some of the sections that are getting introduced by Oncotarget include:
- Microbiology & Immunology
- Aging/ Gerotarget
- All areas of Pharmacology
- Cell and Mol Biology
Oncotarget has played a significant role in eliminating the disease by availing scientific results to all its readers. The journal encourages all scientific researchers to send their articles on the subject of Oncotarget and the newly launched sections. The journal has gained a huge following with people all over the world following every single issue published.